Dr. Mark Dybul

Dr. Dybul, is the CEO of Enochian Biosciences, a company focused on cellular and immune therapies in infectious diseases and cancer. He also is the senior advisor for the Center for Global Health Practice and Impact, and professor in the Department of Medicine at Georgetown University Medical Center. He also is a chair and fellow with the Joep Lange Institute. A well-recognized global health expert and humanitarian, Dr. Dybul served as executive director of the Global Fund to Fight AIDS, Tuberculosis and Malaria, and as the U.S. Global AIDS coordinator, overseeing the implementation of the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR).

Dr. Dybul served as a HIV research fellow at the National Institute for Allergy and Infectious Diseases (NIAID) under director Dr. Anthony Fauci in the late 1990s. He conducted basic and clinical HIV research at NIAID, and eventually conducted the first randomized, controlled trial with combination antiretroviral therapy with HIV patients in Africa.